DE69423753T2 - Polyoximverbindungen und deren herstellung - Google Patents

Polyoximverbindungen und deren herstellung

Info

Publication number
DE69423753T2
DE69423753T2 DE69423753T DE69423753T DE69423753T2 DE 69423753 T2 DE69423753 T2 DE 69423753T2 DE 69423753 T DE69423753 T DE 69423753T DE 69423753 T DE69423753 T DE 69423753T DE 69423753 T2 DE69423753 T2 DE 69423753T2
Authority
DE
Germany
Prior art keywords
baseplate
polyoxime
production
organic molecules
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69423753T
Other languages
English (en)
Other versions
DE69423753D1 (de
Inventor
Keith Rose
Robin Ewart Offord
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/105,904 external-priority patent/US6001364A/en
Priority claimed from US08/114,877 external-priority patent/US6174530B1/en
Application filed by Individual filed Critical Individual
Priority claimed from PCT/IB1994/000093 external-priority patent/WO1994025071A1/en
Application granted granted Critical
Publication of DE69423753D1 publication Critical patent/DE69423753D1/de
Publication of DE69423753T2 publication Critical patent/DE69423753T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69423753T 1993-05-05 1994-05-05 Polyoximverbindungen und deren herstellung Expired - Fee Related DE69423753T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US5759493A 1993-05-05 1993-05-05
US08/105,904 US6001364A (en) 1993-05-05 1993-08-31 Hetero-polyoxime compounds and their preparation by parallel assembly
US08/114,877 US6174530B1 (en) 1993-05-05 1993-08-31 Homogeneous polyoxime compositions and their preparation by parallel assembly
PCT/IB1994/000093 WO1994025071A1 (en) 1993-05-05 1994-05-05 Polyoxime compounds and their preparation

Publications (2)

Publication Number Publication Date
DE69423753D1 DE69423753D1 (de) 2000-05-04
DE69423753T2 true DE69423753T2 (de) 2000-11-02

Family

ID=27369284

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69423753T Expired - Fee Related DE69423753T2 (de) 1993-05-05 1994-05-05 Polyoximverbindungen und deren herstellung

Country Status (11)

Country Link
US (1) US6663869B1 (de)
EP (1) EP0697891B1 (de)
JP (1) JP3734828B2 (de)
AT (1) ATE191148T1 (de)
AU (1) AU686153B2 (de)
CA (1) CA2162157A1 (de)
DE (1) DE69423753T2 (de)
DK (1) DK0697891T3 (de)
ES (1) ES2146649T3 (de)
GR (1) GR3033699T3 (de)
PT (1) PT697891E (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007524584A (ja) * 2003-05-09 2007-08-30 ノボ　ノルディスク　アクティーゼルスカブ 肥満の治療に使用するペプチド
MXPA05011830A (es) * 2003-05-09 2006-01-26 Novo Nordisk As Peptidos para uso en el tratamiento de la obesidad.
US20090203581A1 (en) * 2005-07-18 2009-08-13 Novo Nordisk A/S Novel Peptides for Use in the Treatment of Obesity
WO2008013735A2 (en) * 2006-07-21 2008-01-31 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-d-manno-octulsonic acid
JP2010516652A (ja) * 2007-01-18 2010-05-20 ノボ・ノルデイスク・エー／エス 肥満の治療に使用される新規ペプチド
US20100016238A1 (en) * 2007-01-18 2010-01-21 Novo Nordisk A/S Peptides for Use in the Treatment of Obesity
US20100022446A1 (en) * 2007-01-18 2010-01-28 Novo Nordisk A/S Use of Peptides in Combination with Surgical Intervention for the Treatment of Obesity
NZ602170A (en) 2008-02-08 2014-03-28 Ambrx Inc Modified leptin polypeptides and their uses
WO2010060901A1 (en) * 2008-11-25 2010-06-03 Novo Nordisk A/S Peptides for treatment of obesity
US8647621B2 (en) 2009-07-27 2014-02-11 Fina Biosolutions, Llc Method of producing protein-carbohydrate vaccines reduced in free carbohydrate
JP6564539B1 (ja) 2018-09-14 2019-08-21 長瀬産業株式会社 スルホン酸化合物によるペプチド精製方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444744A (en) 1980-03-03 1984-04-24 Goldenberg Milton David Tumor localization and therapy with labeled antibodies to cell surface antigens
US4622420A (en) 1980-03-18 1986-11-11 The Regents Of The University Of California Chelating agents and method
US4865835A (en) 1982-06-02 1989-09-12 Begent Richard H J Diagnosis and treatment of tumors
US4507466A (en) 1983-01-07 1985-03-26 The Dow Chemical Corporation Dense star polymers having core, core branches, terminal groups
JPS59215321A (ja) 1983-05-23 1984-12-05 Sumitomo Chem Co Ltd 二官能性配位子化合物を結合した反応性高分子
US4707352A (en) 1984-01-30 1987-11-17 Enzo Biochem, Inc. Method of radioactively labeling diagnostic and therapeutic agents containing a chelating group
US4652440A (en) 1984-05-03 1987-03-24 Paik Chang H Method of stably radiolabeling antibodies with technetium and rhenium
IL71947A (en) 1984-05-29 1987-10-30 Yeda Research And Dev Comp Ltd Enzyme hydrazides and method for detection and determination of glycoconjugates
US4659839A (en) 1984-10-10 1987-04-21 Mallinckrodt, Inc. Coupling agents for radiolabeled antibody fragments
US4918164A (en) 1987-09-10 1990-04-17 Oncogen Tumor immunotherapy using anti-idiotypic antibodies
US4678667A (en) 1985-07-02 1987-07-07 501 Regents of the University of California Macrocyclic bifunctional chelating agents
GB8610551D0 (en) 1986-04-30 1986-06-04 Hoffmann La Roche Polypeptide & protein derivatives
IN165717B (de) 1986-08-07 1989-12-23 Battelle Memorial Institute
JPH0611290B2 (ja) 1986-11-05 1994-02-16 住友ベークライト株式会社 ポリビニルアルコ−ルゲルのγ線滅菌法
US4861581A (en) 1986-12-05 1989-08-29 Cancer Biologics, Inc. Detection of necrotic malignant tissue and associated therapy
US5084266A (en) 1988-02-03 1992-01-28 The University Of Melbourne Method for tumor imaging utilizing a labelled tumor specific antibody and a non-tumor reactive antibody
US4857599A (en) 1988-02-08 1989-08-15 The Dow Chemical Company Modified dense star polymers
GB8820377D0 (en) 1988-08-26 1988-09-28 Offord R E Chemical compounds
GB9004538D0 (en) * 1990-02-28 1990-04-25 Offord Robin E Chemical compounds
US5011676A (en) 1990-03-27 1991-04-30 Thomas Jefferson University Method to directly radiolabel antibodies for diagnostic imaging and therapy
ATE152917T1 (de) * 1990-09-28 1997-05-15 Neorx Corp Polymere träger zur freisetzung kovalent gebundener wirkstoffe
GB9102450D0 (en) 1991-02-05 1991-03-20 Sandoz Ltd Improvements in or relating to organic compounds
US5272253A (en) * 1991-07-01 1993-12-21 Eli Lilly And Company Cluster conjugates of drugs with antibodies
WO1994025071A1 (en) 1993-05-05 1994-11-10 Keith Rose Polyoxime compounds and their preparation
US6174530B1 (en) * 1993-05-05 2001-01-16 Gryphon Sciences Homogeneous polyoxime compositions and their preparation by parallel assembly
US6001364A (en) * 1993-05-05 1999-12-14 Gryphon Sciences Hetero-polyoxime compounds and their preparation by parallel assembly

Also Published As

Publication number Publication date
JPH08510210A (ja) 1996-10-29
CA2162157A1 (en) 1994-11-10
ES2146649T3 (es) 2000-08-16
AU6543894A (en) 1994-11-21
JP3734828B2 (ja) 2006-01-11
EP0697891B1 (de) 2000-03-29
GR3033699T3 (en) 2000-10-31
DK0697891T3 (da) 2000-09-04
PT697891E (pt) 2000-09-29
AU686153B2 (en) 1998-02-05
US6663869B1 (en) 2003-12-16
ATE191148T1 (de) 2000-04-15
DE69423753D1 (de) 2000-05-04
EP0697891A1 (de) 1996-02-28

Similar Documents

Publication Publication Date Title
DE69423753D1 (de) Polyoximverbindungen und deren herstellung
ES2141610T3 (es) Compuestos con atomos espiranicos y su uso como materiales electroluminiscentes.
BR8504463A (pt) Resina quimicamente endurecivel,processo para sua preparacao,misturas de compostos e misturas endurecidas de compostos
DK392084D0 (da) Haerdelige materialer
PT98169A (pt) Processo para a preparacao de analogos de oligonucleotidos com ligacoes internucleotido 3'-3' ou 5'-5' terminais
DE59303552D1 (de) Modifiziertes Chlorhexidin-Addukt
KR960007722A (ko) 전도성 측쇄형 액정화합물 및 이를 사용한 배향막
DE69213227D1 (de) Herstellung von zementmörteltrockenmischung
BR9405608A (pt) Processo para preparaçào de polìmeros contendo lignina
CA2032669A1 (en) Process for incorporating o-hydroxyphenyl-s-triazines in organic polymers
AU583624B2 (en) Polymers with pendant isocyanatocarbonyl groups, and their production processes, and compositions comprising them
WO1993015203A3 (en) Polypeptides with fibronectin binding sites as modulators for matrix assembly
CA2033444A1 (en) Production of elastic, compact or cellular moldings based on elastomers containing n-benzylurea groups in bound form, elastomers of this type, and n-benzylpolyoxyalkylene-polyamines which are suitable for this purpose
BR9810210A (pt) Melhoramentos em ou referentes a composiçõespoliméricas
MY111987A (en) Heat resistant resin composition, heat resistant film adhesive and process for producing the same
ES2103194B1 (es) Colorantes reactivos de aluminio-ftalocianina.
KR910004748A (ko) 경화형 조성물
ATE178346T1 (de) Verbesserte zusammensetzungen von bitumen, ihren verfahren zur herstellung und ihre anwendungen
MX9408333A (es) Colorantes de dizaso de la serie estilbeno y procedimiento para su produccion.
ATE71103T1 (de) Organische phosphor-macroringe, verfahren zu ihrer herstellung und ihre verwendungen.
DE68921648D1 (de) Supraleiter und Verfahren zu deren Herstellung.
JPS6420226A (en) Production of modified epoxy resin
KR890011600A (ko) 세포증식 억제성 안트라사이클린 항생제의 안정화된 건식 제제 및 이의 제조방법
TWI255831B (en) Heat resistant molded article
KR900014467A (ko) 폴리아미드수지와 그의 제조방법

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee